SITI WEB ITALIA
CATALOGARE
Informazioni sul dominio e sul sito Web:
paliperidone.it
Informazioni sul sito:
Nome del dominio - paliperidone.it
Titolo del sito - Titolo del sito non disponibile
Vai al sito Web - collegamento bloccato
Site Logo
There is no Open Graph data at paliperidone.it
Informazioni per il dominio paliperidone.it
indirizzo IP:
pu72vnji.edge.easyredir.net. 76.223.34.124 13.248.160.137
Server dei nomi di dominio:
ns5.jnj.com ns1.jnj.com ns3.jnj.com
Tutti i record:
☆ paliperidone.it. 1800 IN SOA ns1.jnj.com. extdnsreqs.its.jnj.com. 2016091613 7200 1800 2592000 1800
☆ paliperidone.it. 1800 IN NS ns5.jnj.com.
☆ paliperidone.it. 1800 IN NS ns3.jnj.com.
☆ paliperidone.it. 1800 IN NS ns1.jnj.com.
Informazioni sul server Whois per paliperidone.it
*********************************************************************
* Please note that the following result could be a subgroup of *
* the data contained in the database. *
* *
* Additional information can be visualized at: *
* http://web-whois.nic.it *
*********************************************************************
Domain: paliperidone.it
Status: ok
Signed: no
Created: 2008-03-17 10:21:55
Last Update: 2023-10-16 00:49:26
Expire Date: 2024-09-30
Registrant
Organization: Janssen Pharmaceutica NV
Address: 30 Turnhoutseweg
Beerse
2340
Belgium
BE
Created: 2022-11-15 21:04:38
Last Update: 2022-11-15 21:04:38
Admin Contact
Name: The Domains
Organization: Janssen Pharmaceutica NV
Address: 30 Turnhoutseweg
Beerse
2340
Belgium
BE
Created: 2022-11-15 21:04:38
Last Update: 2022-11-15 21:04:38
Technical Contacts
Name: Tech Manager
Organization: Johnson & Johnson NCS
Address: 1003 US Hway. 202 N
Raritan
08869
NJ
US
Created: 2015-10-20 23:53:42
Last Update: 2015-10-20 23:53:42
Registrar
Organization: Key-Systems GmbH
Name: KEYSYSTEMS-REG
Web: http://www.key-systems.net
DNSSEC: yes
Nameservers
ns1.jnj.com
ns3.jnj.com
ns5.jnj.com
Brief facts about paliperidone:
Paliperidone, sold under the brand name Invega among others, is an atypical antipsychotic. It is mainly used to treat schizophrenia and schizoaffective disorder. It is marketed by Janssen Pharmaceuticals. The most frequent side effects include headache, insomnia, sleepiness, parkinsonism, dystonia, tremor, dizziness, akathisia, agitation, anxiety, depression, increased weight, nausea, vomiting, constipation, dyspepsia, diarrhea, dry mouth, tiredness, toothache, muscle and bone pain, back pain, asthenia, tachycardia, high blood pressure, prolonged QT interval, upper respiratory tract infection and cough. Paliperidone was approved by the US Food and Drug Administration for the treatment of schizophrenia in December 2006, and in the European Union in June 2007. Paliperidone palmitate is a long-acting injectable formulation of paliperidone palmitoyl ester. It is on the World Health Organization's List of Essential Medicines. Paliperidone is available as a generic medication.
World Health Organization essential medicines
© DMS 2011-